SILVER POINT CAPITAL L.P. purchased 7.1% of their position (397.50K shares) of KEENOVA THERAPEUTICS PLC on the open market
Open‑market purchase worth $35.97M — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/22/2026ACC: 0001193125-26-235195
10% Owner
Since Nov 2025
+397.50K
Net shares
Net buyer
$35.97M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
397.50K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+187.50K
Price / share
$90.50
Trade value
$16.97M
% of position
3.3%
5/19/2026
5.64M→5.83M
Common Stock
Direct
Shares
+210K
Price / share
$90.50
Trade value
$19M
% of position
3.6%
5/20/2026
5.83M→6.04M
Total
Net shares
+397.50K
Net value
$35.97M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/19/2026 | P · Purchase | +187.50K | $90.50 | $16.97M | 3.3% | 5.64M | 5.83M |
| Common Stock Direct | 5/20/2026 | P · Purchase | +210K | $90.50 | $19M | 3.6% | 5.83M | 6.04M |
| Total | +397.50K | $35.97M | ||||||
Derivative Transactions0
No derivative transactions reported